Skip to main content

Advertisement

Springer Nature Link
Log in

Treatment of psoriasis vulgaris by oral administration of 1α-hydroxyvitamin D3—Open-design study

  • Rapid Communications
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

In an open-design study 1α-hydroxyvitamin D3 was administered orally to 17 patiens with psoriasis vulgaris at a dose of 1.0 μg/day for 6 months. More than moderate improvement was observed in 13 (76 %) of the 17 patients from 2.7±0.6 months (mean±SD) after the start of treatment. No side effects of the treatment were observed. The mechanism of the effect of 1α-hydroxyvitamin D3 requires study, but these data suggest that its oral administration is effective for treatment of psoriasis vulgaris.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Weinstein GD, Frost P (1968) Abnormal cell proliferation in psoriasis. J Invest Dermatol 50: 254–259

    PubMed  CAS  Google Scholar 

  2. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T (1981) Differentiation of mouse myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 78: 4990–4994

    Article  PubMed  CAS  Google Scholar 

  3. Miyaura C, Abe E, Kuribayashi T, Tanaka H, Konno K, Nishii Y, Suda T (1981) 1α, 25-Dihydroxyvitamin D3 induced differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 102: 937–943

    Article  PubMed  CAS  Google Scholar 

  4. Colston K, Hirt M, Feldman D (1980) Organ distribution of the cytoplasmic 1,25-dihydroxycholecalciferol receptor in various mouse tissues. Endocrinology 105: 1916–1922

    Google Scholar 

  5. Simpson RU, DeLuca HF (1980) Characterization of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin. Proc Natl Acad Sci USA 77: 5822–5826

    Article  PubMed  CAS  Google Scholar 

  6. Feldman D, Chen T, Hirst M, Colston K, Karasek M, Cone C (1980) Demonstration of 1,25-dihydroxyvitamin D3 receptors in human skin biopsies. J Clin Endocrinol Metab 51: 1463–1465

    PubMed  CAS  Google Scholar 

  7. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T (1983) Regulation of terminal differentiation of cultured mouse epidermal cells by 1α-25-dihydroxyvitamin D3. Endocrinology 113: 1950–1957

    PubMed  CAS  Google Scholar 

  8. Morimoto S, Kumahara Y (1985) A patient with psoriasis cured by 1α-hydroxyvitamin D3. Med J Osaka Univ 35: 51–54

    PubMed  CAS  Google Scholar 

  9. Holick MF, Semmler EJ, Schoes HK, DeLuca HF (1973) 1α-hydroxy derivative of vitamin D3: a highly potent analog of 1α-25-dihydroxy-vitamin D3. Science 180: 190–191

    Article  PubMed  CAS  Google Scholar 

  10. Barton DHR, Hesse RH, Pechet MM, Rizzardo E (1973) A convenient synthesis of 1α-hydroxyvitamin D3. J Amer Chem Soc 95: 2748–2749

    Article  CAS  Google Scholar 

  11. Holick MF, Dasten-Schraufrogel P, Tavela T, DeLuca HF (1975) Biological activity of 1α-hydroxyvitamin D3 in the rat. Arch Biochem Biophys 166: 63–66

    Article  PubMed  CAS  Google Scholar 

  12. Fukushima M, Suzuki Y, Tohira Y, Matsunaga I, Ochi K, Magano H, Nishii Y, Suda T (1975) Metabolism of 1α-hydroxyvitamin D3 to 1α,25-dihydroxyvitamin D3 in perfused rat liver. Biochem Biophys Res Commun 66: 632–638

    Article  PubMed  CAS  Google Scholar 

  13. Brickman AS, Coburn JW, Friedman GR, Okamura WH, Massry SG, Norman AW (1976) Comparison of effect of 1α-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man. J Clin Invest 57: 1540–1547

    Article  PubMed  CAS  Google Scholar 

  14. Lindohlum TS, Sevastikoglou JA, Lindgen U (1977) Treatment of patients with senile, post-menopausal and corticosteroid-induced osteoporosis with 1α-hydroxyvitamin D3 and calcium: short- and long-term effects. Clin Endocrinol 7: 183s-189s

    Google Scholar 

  15. Shimotsuji Y, Seino Y (1980) Competitive protein binding assay for 25-hydroxycholecalciferol. Methods Enzymol 67: 466

    PubMed  CAS  Google Scholar 

  16. Lee S, Morimoto S, Onishi T, Stuji Y, Okada Y, Seino Y, Ishida M, Yamaoka K, Takai S, Miyauchi A, Kumahara Y (1982) Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thryoid. J Clin Endocrinol Metab 55: 361–363

    Article  PubMed  CAS  Google Scholar 

  17. Morimoto S, Tsuji M, Okada Y, Onishi T, Kumahara Y (1980) The effect of oestrogens on human calcitonin secretion after calcium infusion in elderly female subjects. Clin Endocrinol 13: 135–143

    CAS  Google Scholar 

  18. Cram DL (1981) Psoriasis: current advances in etiology and treatment. J Am Acad Dermatol 4: 1–14

    Article  PubMed  CAS  Google Scholar 

  19. Risum G (1973) Psoriasis exacerbated by hypoparathyroidism with hypocalcemia. Br J Dermatol 89: 309–312

    Article  PubMed  CAS  Google Scholar 

  20. MacLaughlin JA, Gang W, Taylor D, Smith E, Holick MF (1985) Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 82: 5409–5412

    Article  PubMed  CAS  Google Scholar 

  21. Morimoto S, Onishi T, Imanaka S, Yukawa H, Kozuka T, Kitano Y, Yoshikawa K, Kumahara Y (1985) Topical administration of 1,25-dihydroxyvitamin D3 for psoriasis: report of five cases. Calcif Tissue Int1 in press

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Geriatrics, Osaka University Medical School, Fukushima-ku, 553, Osaka, Japan

    S. Morimoto, S. Imanaka, K. Fukuo, E. Koh, T. Onishi & Y. Kumahara

  2. Department of Dermatology, Osaka University Medical School, Fukushima-ku, 553, Osaka, Japan

    K. Yoshikawa, T. Kozuka & Y. Kitano

Authors
  1. S. Morimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Yoshikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Kozuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Kitano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Imanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Fukuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Koh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T. Onishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Y. Kumahara
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morimoto, S., Yoshikawa, K., Kozuka, T. et al. Treatment of psoriasis vulgaris by oral administration of 1α-hydroxyvitamin D3—Open-design study. Calcif Tissue Int 39, 209–212 (1986). https://doi.org/10.1007/BF02555120

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02555120

Keywords

Search

Navigation